These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6119820)

  • 1. The heritable translocation assay: its relationship to assessment of genetic risk for future generations.
    Bishop JB; Kodell RL
    Teratog Carcinog Mutagen; 1980; 1(3):305-32. PubMed ID: 6119820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to mutagenicity studies in animals for carcinogenic and mutagenic agents. I. Modification of the heritable translocation test.
    Adler ID
    Teratog Carcinog Mutagen; 1980; 1(1):75-86. PubMed ID: 6119802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose response for heritable translocations induced by acrylamide in spermatids of mice.
    Adler ID; Reitmeir P; Schmöller R; Schriever-Schwemmer G
    Mutat Res; 1994 Sep; 309(2):285-91. PubMed ID: 7520986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-mammal mutagenicity tests: evaluation of five methods.
    Russell LB; Matter BE
    Mutat Res; 1980 May; 75(3):279-302. PubMed ID: 6991917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic effects of 1,3-butadiene and associated risk for heritable damage.
    Pacchierotti F; Adler ID; Anderson D; Brinkworth M; Demopoulos NA; Lähdetie J; Osterman-Golkar S; Peltonen K; Russo A; Tates A; Waters R
    Mutat Res; 1998 Jan; 397(1):93-115. PubMed ID: 9463556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome aberration assays in genetic toxicology testing in vitro.
    Ishidate M; Miura KF; Sofuni T
    Mutat Res; 1998 Aug; 404(1-2):167-72. PubMed ID: 9729363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Commission for Protection Against Environmental Mutagens and Carcinogens. Genetic risk extrapolation from animal data to human disease. A Taskgroup Report. No. 00105.
    Favor J; Layton D; Sega G; Wassom J; Burkhart J; Douglas G; Dearfield K; Brusick D
    Mutat Res; 1995 Aug; 330(1-2):23-34. PubMed ID: 7623868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of TEM-induced reciprocal translocations in F1 sons of CD-1 male mice: comparison of sequential fertility evaluation and cytogenetic analysis.
    Morris SM; Kodell RL; Domon OE; Bishop JB
    Environ Mol Mutagen; 1988; 11(2):215-23. PubMed ID: 3345738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA procedures and policies to estimate risks of injury to the male reproductive system.
    Flamm WG; Dunkel VC
    Prog Clin Biol Res; 1989; 302():21-9; discussion 30-2. PubMed ID: 2755951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heritable translocation test in mice.
    Generoso WM; Bishop JB; Gosslee DG; Newell GW; Sheu CJ; von Halle E
    Mutat Res; 1980 Sep; 76(2):191-215. PubMed ID: 7453713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dominant lethal and heritable translocation methodologies.
    Anderson D; Hodge MC; Palmer S; Purchase IF
    Mutat Res; 1981 Dec; 85(6):417-29. PubMed ID: 7339488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethylene oxide: evaluation of genotoxicity data and an exploratory assessment of genetic risk.
    Natarajan AT; Preston RJ; Dellarco V; Ehrenberg L; Generoso W; Lewis S; Tates AD
    Mutat Res; 1995 Aug; 330(1-2):55-70. PubMed ID: 7623871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic toxicity assessment: employing the best science for human safety evaluation Part VII: Why not start with a single test: a transformational alternative to genotoxicity hazard and risk assessment.
    Ku WW; Aubrecht J; Mauthe RJ; Schiestl RH; Fornace AJ
    Toxicol Sci; 2007 Sep; 99(1):20-5. PubMed ID: 17548889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal experimental design and sample size for the statistical evaluation of data from somatic mutation and recombination tests (SMART) in Drosophila.
    Frei H; Würgler FE
    Mutat Res; 1995 Apr; 334(2):247-58. PubMed ID: 7885379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The measurement of induced genetic change in mammalian germ cells.
    Adler ID; Pacchierotti F; Russo A
    Methods Mol Biol; 2012; 817():335-75. PubMed ID: 22147580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heritable translocation test in mice with triethylenemelamine (TEM) and ergotamine.
    Matter BE
    Mutat Res; 1982 Apr; 104(1-3):177-82. PubMed ID: 7200571
    [No Abstract]   [Full Text] [Related]  

  • 18. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Evaluation of mutagenicity assays for purposes of genetic risk assessment.
    Russell LB; Aaron CS; de Serres F; Generoso WM; Kannan KL; Shelby M; Springer J; Voytek P
    Mutat Res; 1984; 134(2-3):143-57. PubMed ID: 6504066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity in drug development: interpretation and significance of test results.
    Clive D
    Regul Toxicol Pharmacol; 1985 Mar; 5(1):79-100. PubMed ID: 3991935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
    Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
    Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.